Maximize your thought leadership

Certified-PEP Spotlights U.S.-Made Research Peptides with Independent Batch Testing

By Advos•
Certified-PEP is highlighting its U.S.-manufactured research peptide portfolio, emphasizing independent batch testing and accessible documentation for laboratory customers.
Certified-PEP Spotlights U.S.-Made Research Peptides with Independent Batch Testing

Certified-PEP, a U.S.-based supplier of peptides and compounds for laboratory research, is drawing attention to several offerings from its domestically manufactured portfolio while reinforcing its commitment to independent batch testing, accessible documentation, and research-only standards. The company’s catalog includes a range of peptides, blends, and other compounds intended solely for in-vitro laboratory research. Among the products currently available are IllumiNeuro, Mito Blend, Selank/Semax, Tesa/IP, and Tesa/IPA/CJC.

For research customers, the ability to verify the composition and quality of materials is critical. Certified-PEP addresses this by having all product batches tested by an independent third party. Each batch is tested by Vanguard Laboratory, and Certificates of Analysis (COAs) are made available for corresponding products. This provides researchers with analytical information directly associated with the materials they purchase.

Accessibility to this documentation is a key feature. COA information is also accessible directly from product labels through QR codes on every vial. Research customers can use the Vanguard Laboratory reporting system to review available batch-specific testing documentation for Certified-PEP products. This level of traceability allows researchers to confirm the testing status of each batch before use.

The company’s online platform, available via Certified-PEP, is designed for qualified research customers, offering product information, testing documentation, and clearly stated research-use standards to support informed purchasing decisions for laboratory applications. Certified-PEP does not position its products for consumer or clinical applications; all products are intended solely for in-vitro laboratory research and are not for human or veterinary use, consumption, clinical use, diagnosis, treatment, or prevention of disease.

This announcement matters because it underscores a growing demand within the research community for transparency and verifiable quality in research materials. By combining U.S. manufacturing with independent analytical testing, accessible COAs, and vial-level QR codes, Certified-PEP provides researchers a straightforward way to review documentation associated with the specific materials they receive. Batch-level testing and traceability remain central to the company’s approach, which may help set a benchmark for how research suppliers demonstrate product integrity.

As Certified-PEP continues to develop its research portfolio, the company plans to maintain its emphasis on U.S. manufacturing, Vanguard Laboratory testing, batch-specific documentation, product traceability, transparency, and top-tier customer service. For the broader research supply industry, this focus on documentation and testing could pressure competitors to adopt similar standards, ultimately benefiting laboratories that require reliable, well-documented materials for their work.

Advos

Advos

@advos